Intelligence · Clinical pipeline
Oncology R&D Pipeline
Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Quick answer
Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Top sponsors
- First People's Hospital 474 programs
- Chinese Academy of 400 programs
- United Therapeutics Europe 219 programs
- George Institute for 172 programs
- Takeda 163 programs
- HOFFMANN-LA ROCHE 144 programs
- AstraZeneca 143 programs
- MSD Merck Sharp 131 programs
- Regeneron UK 128 programs
- Anaxis Pharma 125 programs
- Telethon Foundation 113 programs
- Novartis India 110 programs
Pipeline programs
-
Hydrochloride anlotinib
Zhongnan Hospital
Uterine Cervical Neoplasms
1 trial -
Hypervision proton surgery
Hospital Authority, Hong Kong
Non-Small Cell Lung Cancer
1 trial -
Hypofraction radiation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Hypofractionated Radiation Therapy
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Hypofractionated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
IORT
The First People's Hospital of Lianyungang
Laryngeal Neoplasms
1 trial -
Immediate CEUS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Cancer
1 trial -
Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)
The First People's Hospital of Lianyungang
CD30+ Peripheral T-cell Lymphoma
1 trial -
Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)
Hospital Authority, Hong Kong
CD30+ Peripheral T-cell Lymphoma
1 trial -
Induction therapy-Pro regimen
The First People's Hospital of Lianyungang
Diffuse Large B-Cell Lymphoma
1 trial -
Intensity-modulated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Intraoperative Radiation Therapy in Malignant Cerebral Tumor
The First People's Hospital of Lianyungang
Glioblastoma
1 trial -
Intraoperative identification method
Xijing Hospital
Thyroid Cancer
1 trial -
Ipilimumab
Iovance Biotherapeutics B.V.
Metastatic Melanoma
1 trial -
LCI+white light
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Early Gastric Cancer
1 trial -
Lenalidomide
The First People's Hospital of Lianyungang
Diffuse Large B Cell Lymphoma
1 trial -
Lidocaine Hydrochloride 2% Injection Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
Lidocaine Hydrochloride, Injectable
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Liver Cancer
1 trial -
Lidocaine IV
Samsung Bioepis NL B.V.
Colorectal Cancer
1 trial -
Linked Color Imaging
Hospital Authority, Hong Kong
Early Gastric Cancer
1 trial -
Liposomal Doxorubicin
United Therapeutics Europe Ltd
Ovarian Cancer
1 trial -
Liquid Biopsy (SPOT-MAS Assay)
Hospital Authority, Hong Kong
Lung Cancer
1 trial -
Liquid Biopsy Early Screening
The First People's Hospital of Lianyungang
Liquid Biopsy for Early Screening of Lung Cancer
1 trial -
Lugol's Solution (1.5%)
Hospital Authority, Hong Kong
Esophageal Squamous Cell Neoplasm
1 trial -
MR/PET
Hospital Authority, Hong Kong
Non-small Cell Lung Cancer
1 trial -
MTBF regimen
The First People's Hospital of Lianyungang
Relapse Leukemia
1 trial -
MV-PRS Sub-study
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Metformin
The First People's Hospital of Lianyungang
Endometrial Cancer
1 trial -
Metoclopramide 10mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Cancer
1 trial -
Mitoxantrone hydrochloride liposome injection
The First People's Hospital of Lianyungang
Diffuse Large B-cell Lymphoma
1 trial -
Mitoxantrone hydrochloride liposome injection30mg/m2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Myeloid Leukemia
1 trial -
NGS01
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Biliary Tract Neoplasms
1 trial -
Nab-paclitaxel
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
Next generation sequencing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Cancer
1 trial -
Nicotine Replacement
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking-Related Carcinoma
2 trials -
Nutrition Intervention
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Nutritional therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cancer
1 trial -
Obinutuzumab
The First People's Hospital of Lianyungang
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
1 trial -
PCNSL-RMTEA
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
PEG-rhG-CSF
The First People's Hospital of Lianyungang
Lymphoma
1 trial -
POHIM-RT
Samsung Bioepis NL B.V.
Cervix Cancer
1 trial -
PSMA PET/CT
The First People's Hospital of Lianyungang
Prostate Adenocarcinoma
1 trial -
PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy
The First People's Hospital of Lianyungang
Prostate Cancer Screening
1 trial -
Paclitaxel Oral Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-Small-Cell Lung Cancer
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancers
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
The First People's Hospital of Lianyungang
Breast Cancers
1 trial -
Peginterferon α-2b plus an anti-PD-1
The First People's Hospital of Lianyungang
Advanced Solid Tumors
1 trial -
Personalized Functional Profiling
Universal Integrated
Oncology
1 trial
Frequently asked questions
How many oncology pipeline programs are tracked?
5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.